Biotechnology
Chemicals
Manufacturing

Codexis

$20.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Pre-Market
$0.00 (0.00%) Pre-Market

Why Robinhood?

You can buy or sell Codexis and other stocks, options, ETFs, and crypto commission-free!

About

Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. Read More The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Employees
132
Headquarters
Redwood City, California
Founded
2002
Market Cap
1.13B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
403.95K
High Today
$21.08
Low Today
$20.58
Open Price
$20.94
Volume
114.22K
52 Week High
$23.05
52 Week Low
$9.30

Collections

Biotechnology
Chemicals
Manufacturing
Pharmaceutical
Medical
Technology
Engineering
Health

News

Yahoo FinanceMar 14

Codexis (CDXS) Q4 Earnings Beat Estimates

Codexis (CDXS) delivered earnings and revenue surprises of 400.00% and -3.34%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

262
Yahoo FinanceMar 7

Codexis, Inc. (NASDAQ:CDXS) Is Expected To Breakeven

Codexis, Inc.’s (NASDAQ:CDXS): Codexis, Inc. discovers, develops, and sells protein catalysts. The US$1.1b market-cap company announced a latest loss of -US$10.9m on 31 December 2018 for its most recent financial year result. Many investors are wondering the rate at which CDXS will turn a profit, with the big question being “when will the company breakeven?” In this article, I will touch on the expectations for CDXS’s growth and when analysts expect the company to become profitable. Check out our latest an...

342
Yahoo FinanceMar 5

Codexis to Participate in Two Investment Conferences in March

REDWOOD CITY, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (CDXS), a leading protein engineering company, announces that management will participate in two upcoming investment conferences: Cowen and Company 39 th Annual Health Care Conference on Tuesday, March 12 at 10:00 a.m. Eastern time (7:00 am Pacific time). The conference is being held at the Boston Marriott Copley Place; on Tuesday, March 12 at 10:00 a.m. Eastern time (7:00 am Pacific time). The conference is being held at the Bosto...

202

Earnings

-$0.17
-$0.09
-$0.02
$0.06
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 9, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.